How many patents does
Ranbaxy Laboratories have?
patents
1,482
families
390
granted
249
applications
1,233
WO
331
US
329
EP
229
CN
44
KR
15
JP
6
RoW
528
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ranbaxy Laboratories
Top ten assignees appearing on patents
2009
| ranbaxy laboratories | 158 |
| ranbaxy lab | 10 |
| kishore, kaushal | 1 |
| aeron, shelly | 1 |
Ranbaxy Laboratories
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| matrix metalloproteinase inhibitors | 54 | 2006 |
| insulin derivatives containing additional disulfide bonds | 29 | 2010 |
| pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors | 27 | 2007 |
| topical retinoid solutions | 26 | 2009 |
| anti dengue activity of cissampelos pareira extracts | 21 | 2009 |
| 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treat… 🛈 | 20 | 2005 |
| process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl ph… 🛈 | 19 | 2005 |
| substituted pyrrole derivatives and their use as hmg-co inhibitors | 17 | 2003 |
| a process for the preparation of intermediates of tetracyclic compounds | 16 | 2007 |
| process for the production of atorvastatin calcium in amorphous form | 16 | 2004 |